FDA Approved: * March 18, 2014 Pharm Company: *AMNEAL PHARMS Category:Malaria
Atovaquone, sold under the brand name Mepron, is a quinone antimicrobial medication for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP).[2]
Atovaquone is a chemical compound that belongs to the class of naphthoquinones. Atovaquone is a hydroxy-1,4-naphthoquinone, an analog of both ubiquinone and lawsone, with antipneumocystic activity.
Contents
1 Medical uses
2 Malaria
3 Research
3.1 COVID-19
4 Veterinary use
5 References
6 Further reading
7 Externa...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion